Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1979 1
1980 3
1981 2
1982 1
1983 1
1984 2
1985 2
1986 2
1987 3
1988 9
1989 3
1990 3
1991 5
1992 8
1993 8
1994 6
1995 11
1996 4
1997 11
1998 7
1999 9
2000 10
2001 9
2002 17
2003 11
2004 9
2005 17
2006 15
2007 13
2008 9
2009 15
2010 7
2011 10
2012 6
2013 4
2014 6
2015 6
2016 10
2017 4
2018 10
2019 6
2020 15
2021 17
2022 13
2023 13
2024 9
2025 7
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

348 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean sugi k[au] (399 results)?
Randomized Phase III Study of Pemetrexed Plus Cisplatin Versus Vinorelbine Plus Cisplatin for Completely Resected Stage II to IIIA Nonsquamous Non-Small-Cell Lung Cancer.
Kenmotsu H, Yamamoto N, Yamanaka T, Yoshiya K, Takahashi T, Ueno T, Goto K, Daga H, Ikeda N, Sugio K, Seto T, Toyooka S, Date H, Mitsudomi T, Okamoto I, Yokoi K, Saka H, Okamoto H, Takiguchi Y, Tsuboi M. Kenmotsu H, et al. Among authors: sugio k. J Clin Oncol. 2020 Jul 1;38(19):2187-2196. doi: 10.1200/JCO.19.02674. Epub 2020 May 14. J Clin Oncol. 2020. PMID: 32407216 Clinical Trial.
[Interstitial pneumonitis].
Hirai F, Toyokawa G, Ohba T, Kitajima H, Yamaguchi M, Maruyama R, Hamatake M, Seto T, Sugio K, Ichinose Y. Hirai F, et al. Among authors: sugio k. Gan To Kagaku Ryoho. 2011 Nov;38(11):1782-4. Gan To Kagaku Ryoho. 2011. PMID: 22083185 Japanese.
Retreatment With EGFR-Tyrosine Kinase Inhibitor After Disease Progression Following Gefitinib Induction and Chemoradiotherapy in EGFR-Mutant Stage III Non-small Lung Cancer: An Efficacy and Safety Analysis of the LOGIK0902/OLCSG0905 Study.
Saeki S, Hotta K, Sakata S, Oda N, Inoue K, Tamura T, Toyozawa R, Harada D, Tanaka K, Inoue K, Shioyama Y, Gemba K, Sasaki T, Bessho A, Kishimoto J, Katsui K, Kiura K, Sugio K. Saeki S, et al. Among authors: sugio k. Cureus. 2025 Jun 23;17(6):e86575. doi: 10.7759/cureus.86575. eCollection 2025 Jun. Cureus. 2025. PMID: 40704256 Free PMC article.
Molecular genetic tumor markers in non-small cell lung cancer.
Oyama T, Osaki T, Baba T, Nagata Y, Mizukami M, So T, Nakata S, Ichiki Y, Uramoto H, Sugaya M, Yoshimatsu T, Morita M, Hanagiri T, Sugio K, Kawamoto T, Yasumoto K. Oyama T, et al. Among authors: sugio k. Anticancer Res. 2005 Mar-Apr;25(2B):1193-6. Anticancer Res. 2005. PMID: 15865065 Free article. Review.
Five-year outcomes with gefitinib induction and chemoradiotherapy in EGFR-mutant stage III non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study.
Hotta K, Saeki S, Sakata S, Yamaguchi M, Harada D, Bessho A, Tanaka K, Inoue K, Inoue K, Gemba K, Kubo T, Sato A, Ichihara E, Watanabe H, Kishimoto J, Shioyama Y, Katsui K, Sugio K, Kiura K. Hotta K, et al. Among authors: sugio k. Int J Clin Oncol. 2025 Mar;30(3):497-503. doi: 10.1007/s10147-025-02696-3. Epub 2025 Feb 5. Int J Clin Oncol. 2025. PMID: 39910007 Free PMC article. Clinical Trial.
CRES3T: A single-arm confirmatory trial of S-1 plus cisplatin with concurrent radical-dose radiotherapy followed by surgery for superior sulcus tumors.
Takamochi K, Suzuki K, Okada M, Niho S, Ishikura S, Oyamada S, Yamaguchi T, Horio H, Ikeda N, Tanaka F, Shiono S, Haruki T, Yoshino I, Ito H, Uramoto H, Okumura N, Iwata H, Saji H, Fujiwara T, Funai K, Ueno T, Sugio K, Tsuboi M; Advanced Clinical Trial Chest Surgery Group ACTG. Takamochi K, et al. Among authors: sugio k. Lung Cancer. 2025 Apr;202:108506. doi: 10.1016/j.lungcan.2025.108506. Epub 2025 Mar 19. Lung Cancer. 2025. PMID: 40120334 Clinical Trial.
Resistance to gefitinib.
Uramoto H, Sugio K, Oyama T, Sugaya M, Hanagiri T, Yasumoto K. Uramoto H, et al. Among authors: sugio k. Int J Clin Oncol. 2006 Dec;11(6):487-91. doi: 10.1007/s10147-006-0609-y. Epub 2006 Dec 25. Int J Clin Oncol. 2006. PMID: 17180521
Challenges in Robotic Lung Lobectomy through the Anterior Approach.
Osoegawa A, Abe M, Miyawaki M, Karashima T, Takumi Y, Takamori S, Sugio K. Osoegawa A, et al. Among authors: sugio k. Ann Thorac Cardiovasc Surg. 2024 Jan 26;30(1):23-00146. doi: 10.5761/atcs.oa.23-00146. Epub 2023 Nov 30. Ann Thorac Cardiovasc Surg. 2024. PMID: 38030280 Free PMC article.
Incidentally proven pulmonary "ALKoma".
Osoegawa A, Nosaki K, Miyamoto H, Kometani T, Hirai F, Ondo K, Seto T, Sugio K, Choi YL, Soda M, Mano H, Ichinose Y. Osoegawa A, et al. Among authors: sugio k. Intern Med. 2010;49(6):603-6. doi: 10.2169/internalmedicine.49.3126. Epub 2010 Mar 15. Intern Med. 2010. PMID: 20228600 Free article.
348 results